| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/20/2004 | CA2175368C Proliferation antagonistic inhibitor of mesenchymal cells |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/20/2004 | CA2087957C Tissue bonding and sealing composition and method of using the same |
| 07/20/2004 | CA2082420C Wound healing composition comprising purified igf-i or igf-ii and a purified tgf-.beta. |
| 07/20/2004 | CA2036733C Immunodominant acetylcholine receptor peptides useful for t-helper cell sensitization |
| 07/15/2004 | WO2004059318A2 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation |
| 07/15/2004 | WO2004058988A2 Binding agents which inhibit myostatin |
| 07/15/2004 | WO2004058977A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 07/15/2004 | WO2004058953A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/15/2004 | WO2004058949A2 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 07/15/2004 | WO2004058946A2 Protein arrays |
| 07/15/2004 | WO2004058943A2 Device and process for the preparation of autologous thrombin serum |
| 07/15/2004 | WO2004058940A2 Sirna-mediated gene silencing |
| 07/15/2004 | WO2004058939A2 TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs |
| 07/15/2004 | WO2004058817A1 Novel proteins and use thereof |
| 07/15/2004 | WO2004058815A2 Centrosome-associated protein and applications thereof |
| 07/15/2004 | WO2004058813A2 Peptides having a high cysteine content |
| 07/15/2004 | WO2004058804A1 Peptides and therapeutic uses thereof |
| 07/15/2004 | WO2004058799A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor |
| 07/15/2004 | WO2004058798A2 Antimicrobial peptides |
| 07/15/2004 | WO2004058795A1 Angiogenic compounds and uses thereof |
| 07/15/2004 | WO2004058324A2 Antithrombotic venous access devices and methods |
| 07/15/2004 | WO2004058307A1 Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof |
| 07/15/2004 | WO2004058306A1 Tumor supression through bicistronic co-expression of p53 and p14arf |
| 07/15/2004 | WO2004058296A1 Remedy for degenerative intervertebral discs |
| 07/15/2004 | WO2004058295A1 Remedy for pemphigoid |
| 07/15/2004 | WO2004058294A1 Uses of interleukin-18 for treating skin disorders associated with uv radiations |
| 07/15/2004 | WO2004058293A1 Methods of diagnosing, preventing, and treating early onset of pulmonary hypertension |
| 07/15/2004 | WO2004058292A2 Methods and compositions for suppressing fibrocyte differentiation |
| 07/15/2004 | WO2004058291A1 Modified hemoglobin and methods of making same |
| 07/15/2004 | WO2004058290A1 Inhibition of hiv replication by expression of late domain peptides in target cells |
| 07/15/2004 | WO2004058289A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 07/15/2004 | WO2004058288A1 Novel therapeutic targets in cancer |
| 07/15/2004 | WO2004058287A2 Methods of treating neurological conditions with hematopoeitic growth factors |
| 07/15/2004 | WO2004058269A1 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 07/15/2004 | WO2004058258A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058250A1 Bone regeneration product for human and veterinary use, containing melatonin as active principle |
| 07/15/2004 | WO2004058242A1 Nutritional composition for oral use |
| 07/15/2004 | WO2004058239A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058219A1 Formulations for the rectal administration of thrombolytically-active agents |
| 07/15/2004 | WO2004058189A2 Chemokine antagonists and uses thereof |
| 07/15/2004 | WO2004058188A2 Vaccine compositions and methods |
| 07/15/2004 | WO2004058186A2 Formulations for pulmonary delivery |
| 07/15/2004 | WO2004058182A2 Use of synergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections |
| 07/15/2004 | WO2004058180A2 Intraoral calculus dissolving gel composition |
| 07/15/2004 | WO2004058178A2 Uses of mammalian cytokine; related reagents |
| 07/15/2004 | WO2004058165A2 Saposing c and receptors as targets for treatment of benign and malignant disorders |
| 07/15/2004 | WO2004058158A2 Treatment of metastatic cancer with the b-subunit of shiga toxin |
| 07/15/2004 | WO2004058154A2 Method of identifying therapeutic agents |
| 07/15/2004 | WO2004058153A2 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
| 07/15/2004 | WO2004058088A2 Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries |
| 07/15/2004 | WO2004057976A1 Ace inhibitory peptides from plant materials |
| 07/15/2004 | WO2004050124A3 Chimaeric molecules |
| 07/15/2004 | WO2004047853A3 Methods for the treatment of chronic pain and compositions therefor |
| 07/15/2004 | WO2004047772A3 Catalytic antioxidants and methods of use |
| 07/15/2004 | WO2004046325A3 Modulation of serine/threonine kinase 16 expression |
| 07/15/2004 | WO2004043348A3 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 07/15/2004 | WO2004042394A3 Method for providing natural therapeutic agents with high therapeutic index |
| 07/15/2004 | WO2004042027A3 Allele-specific rna interference |
| 07/15/2004 | WO2004039329A3 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| 07/15/2004 | WO2004037277A3 Use of ingap for reversing diabetes |
| 07/15/2004 | WO2004033634A3 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 07/15/2004 | WO2004032708A3 Vasoregulating compounds and methods of their use |
| 07/15/2004 | WO2004031412A3 Method for diagnosing pancreatic cancer |
| 07/15/2004 | WO2004031224A3 Hbv mutations associated with reduced susceptibility to adefovir |
| 07/15/2004 | WO2004030650A3 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/15/2004 | WO2004030630A3 Focal calcium channel modulation |
| 07/15/2004 | WO2004028239A3 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 07/15/2004 | WO2004022593A3 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 07/15/2004 | WO2004019911A3 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 07/15/2004 | WO2004019878A3 Adzymes and uses thereof |
| 07/15/2004 | WO2004016653A3 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 07/15/2004 | WO2004016211A3 Pi3k antagonists as radiosensitizers |
| 07/15/2004 | WO2004012673A3 Methods and reagents relating to inflammation and apoptosis |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003106681A3 Antisense oligonucleotides against pim1 |
| 07/15/2004 | WO2003106647A3 Antisense modulation of junctional adhesion molecule 3 expression |
| 07/15/2004 | WO2003101404A3 Preparations for topical skin use and treatment |
| 07/15/2004 | WO2003100034A3 Dentritic cell nodes |
| 07/15/2004 | WO2003099202A3 Beta-secretase inhibitors |
| 07/15/2004 | WO2003093431A3 Ablated slam-dependent entry |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003089608A3 Drg11-responsive (dragon) gene family |
| 07/15/2004 | WO2003088894A3 A multi component controlled release system for anhydrous cosmetic compositions |
| 07/15/2004 | WO2003087195A3 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003078579A3 Compositions and methods for treating emphysema |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003066670A3 Dipeptides and tripeptides with anti-inflammatory activity |
| 07/15/2004 | WO2003065974A3 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003057831A3 Dtat fusion toxin |
| 07/15/2004 | WO2003057142A3 Antisense modulation of macrophage inflammatory protein 3-alpha expression |
| 07/15/2004 | WO2003051912A9 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2003033645A3 Synthetic peptides and dna sequences for treatment of multiple sclerosis |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |